100 related articles for article (PubMed ID: 8304205)
1. Variable pharmacodynamics of antifolates in squamous cell carcinoma of the head and neck.
Braakhuis BJ; Jansen G; Peters GJ
Adv Exp Med Biol; 1993; 338():671-4. PubMed ID: 8304205
[No Abstract] [Full Text] [Related]
2. Antitumor efficacy of classical non-polyglutamylatable antifolates that inhibit dihydrofolate reductase.
Abraham A; Nair MG; McGuire JJ; Galivan J; Kisliuk RL; Vishnuvajjala BR
Adv Exp Med Biol; 1993; 338():663-6. PubMed ID: 8304202
[No Abstract] [Full Text] [Related]
3. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma.
Braakhuis BJ; Jansen G; Noordhuis P; Kegel A; Peters GJ
Biochem Pharmacol; 1993 Dec; 46(12):2155-61. PubMed ID: 7506025
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate.
van der Laan BF; Jansen G; Kathmann GA; Westerhof GR; Schornagel JH; Hordijk GJ
Int J Cancer; 1992 Jul; 51(6):909-14. PubMed ID: 1639538
[TBL] [Abstract][Full Text] [Related]
5. Identification of a reduced folate/methotrexate carrier in human KB-cells expressing high levels of membrane associated folate binding protein.
Westerhof GR; Schornagel JH; Rijnboutt S; Pinedo HM; Jansen G
Adv Exp Med Biol; 1993; 338():771-4. PubMed ID: 8304226
[No Abstract] [Full Text] [Related]
6. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
[TBL] [Abstract][Full Text] [Related]
7. New thiophene substituted 10-deazaaminopterins: synthesis and biological evaluation.
Abraham A; McGuire JJ; Galivan J; Vishnuvajjala BR; Nair MG
Adv Exp Med Biol; 1993; 338():421-4. PubMed ID: 8304149
[TBL] [Abstract][Full Text] [Related]
8. Toxic dermatitis induced by 10-ethyl-10-deaza-aminopterin (10-EdAM), a novel antifolate.
Verweij J; Schornagel J; de Mulder P; Henzen-Logmans S; Cognetti F; Clavel M; Vermorken J
Cancer; 1990 Nov; 66(9):1910-3. PubMed ID: 2224785
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM).
Brown DH; Braakhuis BJ; Van Dongen GA; Snow GB
Otolaryngol Head Neck Surg; 1990 Jan; 102(1):20-5. PubMed ID: 2106113
[TBL] [Abstract][Full Text] [Related]
10. Studies on the cross resistance of folylpolyglutamate synthetase-deficient, methotrexate-resistant CCRF-CEM human leukemia sublines.
McGuire JJ; Heitzman KJ; Haile WH; Russell CA; McCloskey DE; Piper JR
Adv Exp Med Biol; 1993; 338():667-70. PubMed ID: 8304203
[No Abstract] [Full Text] [Related]
11. Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.
Holden SA; Teicher BA; Robinson MF; Northey D; Rosowsky A
Cancer Chemother Pharmacol; 1995; 36(2):165-71. PubMed ID: 7767954
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
Li WW; Lin JT; Schweitzer BI; Bertino JR
Mol Pharmacol; 1991 Nov; 40(5):854-8. PubMed ID: 1719370
[TBL] [Abstract][Full Text] [Related]
13. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
Chen G; Wright JE; Rosowsky A
Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
[TBL] [Abstract][Full Text] [Related]
14. Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenografts.
Brown DH; Braakhuis BJ; van Dongen GA; van Walsum M; Bagnay M; Snow GB
Anticancer Res; 1989; 9(6):1549-52. PubMed ID: 2627109
[TBL] [Abstract][Full Text] [Related]
15. Determinants of the disparate antitumor effects of (6R)5,10-dideaza-5,6,7,8- tetrahydrofolate and methotrexate toward methotrexate resistant CCRF-CEM cells, characterized by severely impaired antifolate membrane transport.
Matherly LH; Angeles SM
Adv Exp Med Biol; 1993; 338():783-6. PubMed ID: 8304229
[No Abstract] [Full Text] [Related]
16. Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization.
McGuire JJ; Bergoltz VV; Heitzman KJ; Haile WH; Russell CA; Bolanowska WE; Kotake Y; Haneda T; Nomura H
Cancer Res; 1994 May; 54(10):2673-9. PubMed ID: 8168096
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
[TBL] [Abstract][Full Text] [Related]
18. Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.
Wang ES; O'Connor O; She Y; Zelenetz AD; Sirotnak FM; Moore MA
Leuk Lymphoma; 2003 Jun; 44(6):1027-35. PubMed ID: 12854905
[TBL] [Abstract][Full Text] [Related]
19. CONTINUOUS INTRA-ARTERIAL INFUSION OF METHOTREXATE FOR RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK.
ACQUARELLI MJ; FEDER RJ; GORDON HE
Am Surg; 1964 Jul; 30():423-30. PubMed ID: 14179036
[No Abstract] [Full Text] [Related]
20. Synthesis of the 7-hydroxy metabolites of methotrexate and 10-ethyl-10-deazaaminopterin.
Dawson MI; O'Krongly D; Hobbs PD; Barrueco JR; Sirotnak FM
J Pharm Sci; 1987 Aug; 76(8):635-8. PubMed ID: 11002823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
